Vertex Pharmaceuticals
VRTX
VRTX
411 hedge funds and large institutions have $21.7B invested in Vertex Pharmaceuticals in 2014 Q2 according to their latest regulatory filings, with 58 funds opening new positions, 136 increasing their positions, 162 reducing their positions, and 39 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
411
Holders Change
+16
Holders Change %
+4.05%
% of All Funds
11.82%
Holding in Top 10
6
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+50%
% of All Funds
0.17%
New
58
Increased
136
Reduced
162
Closed
39
Calls
$910M
Puts
$724M
Net Calls
+$186M
Net Calls Change
+$163M
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$608M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$193M |
| 3 |
JPMorgan Chase & Co
New York
|
+$192M |
| 4 |
Norges Bank
Oslo,
Norway
|
+$147M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
+$124M |
Top Sellers
| 1 |
AllianceBernstein
Nashville,
Tennessee
|
-$120M |
| 2 |
O
OppenheimerFunds
New York
|
-$112M |
| 3 |
Wells Fargo
San Francisco,
California
|
-$100M |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
-$99.1M |
| 5 |
D.E. Shaw & Co
New York
|
-$92.2M |
